Lumpy Skin Disease

Chapter 1: Introduction to lumpy skin disease.- Chapter 2: General description of lumpy skin disease.- Chapter 3: Economic impact of lumpy skin disease.- Chapter 4: Geographic distribution of lumpy skin disease.- Chapter 5: Current legislation and trade recommendations. Part I: Lumpy skin disease virus: Chapter 6: Taxonomy.- Chapter 7: Morphology.- Chapter 8: Genome.- Chapter 9: Replication in a host.- Chapter 10: Propagation of the virus in vitro.- Chapter 11: Persistence and stability of the virus.- Chapter 12:  Immunity.- Chapter 13: Epidemiology and transmission. Part II: Early detection of lumpy skin disease, diagnostic tools and treatment. Chapter 14: Clinical signs.- Chapter 15: Sample collection and transport.- Chapter 16: Diagnostic tools.- Chapter 17: Treatment of lumpy skin disease. Part III: Control and eradication. Chapter 18: Vaccines against lumpy skin disease and vaccination strategies.- Chapter 19: Slaughter of infected and in-contact animals.- Chapter 20:Animal movement control and quarantine.- Chapter 21: Vector surveillance and control.- Chapter 22: Decontamination and disinfection.- Chapter 23: Active and passive surveillance.

Dr. Eeva Tuppurainen is an independent veterinary expert for lumpy skin disease (LSD), sheeppox (SPP) and goatpox (GTP). For more than a decade, she headed a UK based the World Organization for Animal Health (OIE) reference laboratory for LSD, SPP and GTP. Her responsibilities included provision of diagnostic services, technical assistance and training on capripoxviruses (CaPV) for the OIE Member States. In this role, she was responsible for implementing various research projects on the CaPV field.

During the recent LSD outbreaks in Europe and the northern Caucasus, she has served as a team leader for several European Union (EU) Community Veterinary Emergency Team (CVET) missions, followed by a series of sustained technical assistance missions to the LSD affected and at-risk Balkan countries under the framework of the EU Better Training Safer Food-initiative. In early 2017 she contributed as a short term external consultant for FAO LSD projects, providing disease expertise in designing effective disease control and eradication measures, preparing training courses, awareness material, LSD Field Manual and a contingency plan template. Currently, she is engaged as a Senior Animal Health Expert, in an EU funded project in the northern part of Cyprus.

Dr. Shawn Babiuk received a Bachelor of Science in Biochemistry from the University of Saskatchewan in 1997 and a Doctorate in Pharmaceutical Sciences from the University of Saskatchewan in 2003. He completed postdoctoral training in Saskatoon on genomics with Pyxis Genomics Canada and on vaccine development at Vaccine & Infectious Disease Organization, University of Saskatchewan. In 2005, he moved to the National Centre for Foreign Animal Disease in Winnipeg as a research scientist for the Canadian Food Inspection Agency. In 2006, he became an Adjunct Assistant Professor in the Department of Immunology at the University of Manitoba. Dr. Babiuk's research is focused on foreign animal disease. His